Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124582622 | 12458262 | 2 | F | 20160628 | 20160613 | 20160707 | EXP | GB-ALEXION PHARMACEUTICALS INC-A201504947 | ALEXION | 0.00 | Y | 0.00000 | 20160707 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124582622 | 12458262 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||||
124582622 | 12458262 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||||
124582622 | 12458262 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124582622 | 12458262 | 1 | Thrombotic microangiopathy |
124582622 | 12458262 | 2 | Bone marrow transplant |
124582622 | 12458262 | 3 | Off label use |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124582622 | 12458262 | OT |
124582622 | 12458262 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124582622 | 12458262 | Off label use | |
124582622 | 12458262 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |